ACE and infection: A large retrospective analysis [143], published in May 2020 on the NEJM, involving a total of 12,594 patients tested for SARS-CoV2 in New York City, explored the relations between the use of several anti-hypertensive drugs (ACE-inhibitors, ARBs, calcium channel blockers, beta-blockers, thiazide diuretics) and the risk of infection or severe illness.